Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

March 31, 2009

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG

gemcitabine hydrochloride

Given IV

DRUG

alvocidib

Given IV

OTHER

pharmacological study

Correlative studies

Trial Locations (3)

Memorial Sloan Kettering Cancer Center, New York

Massachusetts General Hospital Cancer Center, Boston

Dana-Farber Cancer Institute, Boston

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00072436 - Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | Biotech Hunter | Biotech Hunter